Answers are grounded in this paper and cite their sources.
The title of the report of a clinical trial can be indicative (such as "Newbetalol in the treatment of tachycardias") or informative ("Newbetalol prevents tachycardias"). 1 Rosner believes informative titles are "improper and imprudent" and a symptom of "science as product." 2 Weiss objected to an "overly optimistic" title beginning "Improved survival . . ." from a pilot study using historical controls. 3 According to the popperian model, hypotheses cannot be proved but only supported or rejected, and then only to an arbitrary level of statistical significance. This makes an informative title incorrect, but rejected hypotheses live on in such titles.
No takes yet. Share an insight, caveat, or question.
Neville W. Goodman (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: